Neo Soma Healthcare Review
Best for: Patients wanting a single-platform DTC checkout that bundles compounded GLP-1 with adjacent men's/women's wellness products (sexual health, peptide therapies, NAD+). LegitScript verified. Pricing model: first-month discount on semaglutide ($99 → $199) is the entry hook.
Neo Soma Healthcare (neosomahealthcare.com) is a multi-product DTC telehealth platform combining compounded GLP-1 weight management with sexual-health and anti-aging product lines. **Verbatim positioning: 'Weight Loss, Sexual Health and Anti-Aging Made Simple.'** GLP-1 menu: compounded semaglutide at $99 first month → $199/month standard, compounded tirzepatide at $330 initial purchase. Adjacent product lines: Ignios (men's sexual health) $164/mo, Connect (women's sexual health) $164/mo, Sermorelin $179 every 4 weeks, NAD+ $175 every 4 weeks. **LegitScript verification badge present** on site. **Verbatim FDA disclaimer present: 'Compounded medications prescribed by Neo Soma providers are not FDA-approved.'** Pharmacy partner (503A vs 503B facility identity) not named. States served not enumerated; site implies nationwide reach but no per-state availability table surfaced. Telehealth-only intake described as 'under 20 minutes.' Differentiator claims: 'Fastest shipping compared to the others,' 'All supplies included,' 'Unlimited follow-up messaging with your doctor,' discreet shipping. Medical director not identified. Live-verified 2026-05-24.
Medium confidence · Last verified 2026-05-24 via Eli Marsden · How we verify provider data
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
Neo Soma Healthcare is a solid telehealth option with balanced features and pricing.
Score Breakdown
Drugs Offered
Neo Soma Healthcare prescribes the following GLP-1 medications. Tap a drug to read our clinical guide with FDA label info, dosing schedules, side effects, and trial data.
Pricing
| Dose | Form | Price/mo |
|---|---|---|
| All doses (semaglutide first-month promo) | compounded | $99 |
| All doses (semaglutide standard) | compounded | $199 |
| All doses (tirzepatide initial purchase) | compounded | $330 |
✓ Pros
- •**LegitScript verification badge** present on site
- •**Verbatim FDA compounded-medication disclaimer** present (transparency win)
- •**Pricing surfaced publicly** for all 6 product lines
- •Multi-product platform (GLP-1 + sexual health + peptide therapies)
- •First-month discount on semaglutide ($99 entry hook)
- •Quick (<20 min) online intake
✗ Cons
- •**Pharmacy partner (503A vs 503B) not named**
- •**States served not enumerated** publicly — no per-state availability table
- •**Medical director not identified**
- •Standard semaglutide pricing ($199/mo) above the cheapest compounded providers ($150-180/mo segment)
- •Tirzepatide entry pricing ($330) above the cheapest compounded providers (~$200-250/mo)
- •Multi-product platform — less GLP-1-specific clinical depth than single-product specialists
Ready to start with Neo Soma Healthcare?
Starting at $99/month. See current pricing and start your free consultation.
Sources & methodology
Our Neo Soma Healthcare review applies the same 6-dimension scoring framework we use for every provider. Pricing, FDA approval status, compounding rules, and clinical-trial efficacy claims are sourced from the primary regulatory and peer-reviewed literature below.
Sources & methodology — as of May 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
Alternatives to Neo Soma Healthcare
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Ready to start with Neo Soma Healthcare?
Starting at $99/month. See current pricing and start your free consultation.